Searched for
TRULICITY
Cipla to sell Lilly's weight-loss drug in IndiaEli Lilly and Cipla have joined forces. Cipla will now market Lilly's popular weight-loss drug in India. The medication will be sold under ...- Eli Lilly's experimental GLP-1 pill may rival Ozempic and Wegovy? Check how much weight you could loseEli Lilly's experimental weight loss pill, orforglipron, demonstrated an average weight loss of 12% in a late-stage trial, falling short of...
- Pharma major Eli Lilly claims its weight loss drug reduces cardiovascular risks in Type 2 diabetes patientsEli Lilly's Mounjaro demonstrates significant cardiovascular benefits for Type 2 diabetes patients with heart disease, reducing mortality a...
- Popular US-based weight loss drug maker Eli Lilly plans to launch medicine in India next yearEli Lilly will launch Mounjaro in India in 2025. The drug treats type 2 diabetes and obesity. Lilly received marketing authorization in Jul...
- Weight-loss drugs didn't curb health costs within two years, data showU.S. health insurance claims analysis shows that two years after starting Novo Nordisk's Wegovy or similar GLP-1 drugs, annual medical cost...
- Eli Lilly could launch obesity drug in India next year, CEO saysEli Lilly plans to launch its diabetes and obesity drug, Mounjaro, in India next year. The drug contains tirzepatide and is sold as Zepboun...
- Cipla vows to crack diabetes segment with licensed branded portfolio"Cipla historically has always been a big respiratory and acute player but not that big in the diabetes area," said Umang Vohra, managing d...
- Blood sugar spikes, rapid heartbeats, diarrhoea: Learn 6 six effects of dropping Ozempic, the weight-loss ‘miracle’ drugWhat happens if you stop taking Ozempic?
- How a TikTok trend for weight loss triggered a diabetes drug shortageOn TikTok, some videos featuring the hashtag Ozempic have been viewed more than a million times. Sponsored ads on Google promise weight los...
- Cipla expects sales of branded generics to cross $1 billion this fiscalCipla's branded generics business reported sales of around ₹6,000 crore in FY21. The drug maker's India business, which consists of prescri...
- Eli Lilly lays off 120 employees in India after Cipla saleThe sales team was informed of the decision at a virtual town hall organised last week in conjunction with the media announcement of the de...
- Cipla to sell Lilly's Trulicity, Humalog diabetes treatments in IndiaThis will allow Cipla to expand access to the drugs in the country with the second-highest number of diabetic people in the world. India ha...
- India gets its first 'weekly' injectible drug for Type 2 diabetesOut of the two types of diabetes, it is believed that Type 2 diabetes occurs in 80% to 90% of the patients worldwide.
- Eli Lilly launches once-a-week diabetes drug in IndiaThe once-a-week non-insulin injectable Trulicity is distinct in the duration of dosage compared to products like Novo Nordisk's Victoza or ...
Load More
